APPLICATION
ANDA214949
TYPE
ANDA
ORIGINAL APPROVAL
2022-02-28
LATEST ACTION
2022-02-28
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
OSELTAMIVIR PHOSPHATEDiscontinued
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML · FOR SUSPENSION · ORAL
Approval history
2022-02-28UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.